LAVA Therapeutics
LVTX
LVTX
13 hedge funds and large institutions have $34.1M invested in LAVA Therapeutics in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
-4
Holders Change %
-23.53%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$2.79M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$343K |
| 3 |
CC
Cannell Capital
Alta,
Wyoming
|
+$63.5K |
| 4 |
Axa
Paris,
France
|
+$5.48K |
